Edition:
United Kingdom

Dania Nadeem

Ironwood to cut 100 jobs after acid reflux drug fails study

29 Sep 2020

Ironwood Pharmaceuticals Inc said on Tuesday it will cut about 100 jobs after its therapy to treat digestive disorder refractory gastroesophageal reflux failed to significantly reduce heartburn severity in a late-stage trial.

Neurocrine launches Parkinson's therapy as COVID-19 related disruptions ease

14 Sep 2020

Neurocrine Biosciences Inc on Monday launched its add-on treatment for patients with Parkinson's disease nearly five months after Food and Drug Administration's approval, as the COVID-19 pandemic delayed its roll out in the United States.

Medtronic profit beats as demand for devices rebounds from pandemic lows

25 Aug 2020

Medtronic Plc beat analysts' estimates for quarterly profit on Tuesday, and forecast improving demand for its medical devices in the back half of the year as patients catch up on procedures deferred during coronavirus-induced lockdowns.

REFILE-UPDATE 3-Alzheimer's drug from Biogen to get speedy U.S. review

07 Aug 2020

Aug 7 The U.S. Food and Drug Administration will conduct an expedited review of an experimental Alzheimer's drug from Biogen Inc and Japan's Eisai Co Ltd, the companies said on Friday, the first application in 17 years to be reviewed by the agency for a treatment of the mind-robbing disease.

Becton on track to make one billion syringes to help COVID-19 vaccination

06 Aug 2020

Becton Dickinson and Co said on Thursday it was on track to make 1 billion syringes in the next 12-18 months to meet demand for COVID-19 vaccination when approved, as the medical device maker reported quarterly revenue below estimates, sending its shares down nearly 9%.

Quest medical lab sees COVID-19 test speed at 'acceptable' level by September

23 Jul 2020

Quest Diagnostics Inc said on Thursday it expects to cut week-long turnaround times for COVID-19 tests by more than half to get to "acceptable" levels by September, responding to concerns that slow testing is hampering the U.S. response.

U.S. FDA comes out with guidance for COVID-19 vaccine approval

30 Jun 2020

The U.S. Food and Drug Administration on Tuesday released guidance for approving a coronavirus vaccine, saying the vaccine has to prevent or decrease disease severity in at least 50% of people who are inoculated.

Evofem's gel first non-hormonal contraceptive to get approval in over 30 years

22 May 2020

Evofem Biosciences Inc's birth control gel received the U.S. Food and Drug Administration's approval on Friday, making it the first non-hormonal contraceptive for women in over three decades, sending its shares up 3.6%.

World News